Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
doi:10.5664/jcsm.26527
The analysis on the respective cohorts was based on the following safety outcomes over 5 years from drug initiation: DKA, hypoglycaemia requiring admission to secondary care, urinary tract infection (UTI), pyelonephritis, candidiasis of the lower genital tract, acute pancreatitis and gastrointestinal upset
SubQ delivers a slower, more sustained release profile
Acta 1830 (5), 32173266
Ozempic targets only GLP-1 receptors, while Mounjaro activates both GLP-1 and GIP receptors, potentially explaining its edge in A1C reduction and weight loss results
US$ 21.32
US$ 25.76
US$ 28.23
US$ 26.16
US$ 24.91
US$ 22.59
US$ 27.47
US$ 20.30
US$ 28.64
US$ 20.94
